A Study of CS1001 in Subjects With Stage IV Non-Small Cell Lung Cancer
Clinical trial NCT03789604 · COMPLETED
Trial details
- NCT number
- NCT03789604
- Sponsor
- CStone Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-13
- Primary completion
- 2023-05-15
- Enrollment
- 479
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.